Recursion Pharmaceuticals Inc (RXRX)
6.93
-0.04
(-0.57%)
USD |
NASDAQ |
Nov 07, 16:00
6.90
-0.03
(-0.43%)
Pre-Market: 08:29
Recursion Pharmaceuticals Revenue (Annual): 43.88M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 43.88M |
December 31, 2022 | 39.68M |
December 31, 2021 | 10.00M |
Date | Value |
---|---|
December 31, 2020 | 3.413M |
December 31, 2019 | 1.711M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.711M
Minimum
2019
43.88M
Maximum
2023
19.74M
Average
10.00M
Median
2021
Revenue (Annual) Benchmarks
Eli Lilly and Co | 34.12B |
Pfizer Inc | 58.50B |
Revance Therapeutics Inc | 234.04M |
Twist Bioscience Corp | 245.11M |
NovaBay Pharmaceuticals Inc | 14.73M |